Predicting treatment risk using geriatric assessment and genetic profiling for AML may impact early rates of mortality among patients aged 60 years or older. Geriatric assessment showed a high rate of ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. AI, and especially agentic AI tools, are evolving at a rapid speed, with the use of AI ...
The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years or older receiving lower intensity treatment (LIT), including the adoption ...
The ELN 2024 framework offers better stratification for AP/BP MPN, but gaps remain between intermediate and adverse groups. The study analyzed 211 patients, showing modest response rates and ...
TORONTO--(BUSINESS WIRE)--Minerva, a leader in Anti-Money Laundering (AML) compliance technology, today announced a channel program that will provide partners and their customers with seamless access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback